Copyright Reports & Markets. All rights reserved.

Global Rufinamide Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Rufinamide Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Tablets
      • 1.4.3 Oral suspension
    • 1.5 Market by Application
      • 1.5.1 Global Rufinamide Market Share by Application (2014-2025)
      • 1.5.2 Adults
      • 1.5.3 Pediatric patients
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Rufinamide Market Size
    • 2.2 Rufinamide Growth Trends by Regions
      • 2.2.1 Rufinamide Market Size by Regions (2014-2025)
      • 2.2.2 Rufinamide Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Rufinamide Market Size by Manufacturers
      • 3.1.1 Global Rufinamide Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Rufinamide Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Rufinamide Market Concentration Ratio (CR5 and HHI)
    • 3.2 Rufinamide Key Players Head office and Area Served
    • 3.3 Key Players Rufinamide Product/Solution/Service
    • 3.4 Date of Enter into Rufinamide Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Rufinamide Market Size by Type (2014-2019)
    • 4.2 Global Rufinamide Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Rufinamide Market Size (2014-2019)
    • 5.2 Rufinamide Key Players in United States
    • 5.3 United States Rufinamide Market Size by Type
    • 5.4 United States Rufinamide Market Size by Application

    6 Europe

    • 6.1 Europe Rufinamide Market Size (2014-2019)
    • 6.2 Rufinamide Key Players in Europe
    • 6.3 Europe Rufinamide Market Size by Type
    • 6.4 Europe Rufinamide Market Size by Application

    7 China

    • 7.1 China Rufinamide Market Size (2014-2019)
    • 7.2 Rufinamide Key Players in China
    • 7.3 China Rufinamide Market Size by Type
    • 7.4 China Rufinamide Market Size by Application

    8 Japan

    • 8.1 Japan Rufinamide Market Size (2014-2019)
    • 8.2 Rufinamide Key Players in Japan
    • 8.3 Japan Rufinamide Market Size by Type
    • 8.4 Japan Rufinamide Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Rufinamide Market Size (2014-2019)
    • 9.2 Rufinamide Key Players in Southeast Asia
    • 9.3 Southeast Asia Rufinamide Market Size by Type
    • 9.4 Southeast Asia Rufinamide Market Size by Application

    10 India

    • 10.1 India Rufinamide Market Size (2014-2019)
    • 10.2 Rufinamide Key Players in India
    • 10.3 India Rufinamide Market Size by Type
    • 10.4 India Rufinamide Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Rufinamide Market Size (2014-2019)
    • 11.2 Rufinamide Key Players in Central & South America
    • 11.3 Central & South America Rufinamide Market Size by Type
    • 11.4 Central & South America Rufinamide Market Size by Application

    12 International Players Profiles

    • 12.1 Eisai
      • 12.1.1 Eisai Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Rufinamide Introduction
      • 12.1.4 Eisai Revenue in Rufinamide Business (2014-2019)
      • 12.1.5 Eisai Recent Development
    • 12.2 Glenmark Pharms
      • 12.2.1 Glenmark Pharms Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Rufinamide Introduction
      • 12.2.4 Glenmark Pharms Revenue in Rufinamide Business (2014-2019)
      • 12.2.5 Glenmark Pharms Recent Development
    • 12.3 Mylan
      • 12.3.1 Mylan Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Rufinamide Introduction
      • 12.3.4 Mylan Revenue in Rufinamide Business (2014-2019)
      • 12.3.5 Mylan Recent Development
    • 12.4 West-ward Pharms
      • 12.4.1 West-ward Pharms Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Rufinamide Introduction
      • 12.4.4 West-ward Pharms Revenue in Rufinamide Business (2014-2019)
      • 12.4.5 West-ward Pharms Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders.
      In 2018, the global Rufinamide market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Rufinamide status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rufinamide development in United States, Europe and China.

      The key players covered in this study
      Eisai
      Glenmark Pharms
      Mylan
      West-ward Pharms
      ...

      Market segment by Type, the product can be split into
      Tablets
      Oral suspension

      Market segment by Application, split into
      Adults
      Pediatric patients

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Rufinamide status, future forecast, growth opportunity, key market and key players.
      To present the Rufinamide development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Rufinamide are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now